| 名称
|
Gastric Inhibitory Peptide (GIP), human
|
| 编码
|
[10040-31-1]
|
| 别名
|
Gastric Inhibitory Peptide (GIP), human
|
| 纯度
|
80%，90%，95%，98%，99%
|
| 重量
|
1mg,5mg,10mg,50mg,100mg,1g
|
| 序列（单字母缩写）
|
YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
|
| 序列（三字母缩写）
|
H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH (trifluoroacetate salt)
|
| 基本描述
|
GIP fragment that presents potent insulinotropic activity in the isolated perfused rat pancreas, but greatly inhibits somatostatinotropic activity in the isolated perfused rat stomach. The site responsible for insulinotropic activity lies between 19 and 30 of GIP.
|
| 溶解度
|
|
| 分子量
|
4983.6
|
| 化学式
|
C226H338N60O66S1
|
| 存储条件
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| 注释
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
A. Moody et al., FEBS Letters, 123, 205 (1981)
|
| C端
|
|
| N端
|
|
| 化学桥
|
|